Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Nuvation Bio (NUVB)
NYSE:NUVB
Nuvation Bio (NUVB) Stock Price & Analysis
65 Followers
NUVB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.59 - $6.05
Previous Close$2.4
Volume275.23K
Average Volume (3M)862.94K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$673.95M
Total Debt (Recent Filing)$4.47M
Price to Earnings (P/E)-4.8
Beta0.68
Next EarningsMar 09, 2023
EPS Estimate-$0.12
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$3.25
EPS (TTM)-0.50
Shares Outstanding218,392,607
R-Squared0.05
Standard Deviation0.15
10 Day Avg. Volume427,536
30 Day Avg. Volume862,940
Price to Book (P/B)0.80
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside35.42% Upside
Rating ConsensusModerate Buy
Alpha-0.04
Number of Analyst Covering2
Nuvation Bio News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NUVB FAQ
What was Nuvation Bio’s price range in the past 12 months?
Nuvation Bio lowest stock price was $1.59 and its highest was $6.05 in the past 12 months.
What is Nuvation Bio’s market cap?
Currently, no data Available
When is Nuvation Bio’s upcoming earnings report date?
Nuvation Bio’s upcoming earnings report date is Mar 09, 2023 which is in 30 days.
How were Nuvation Bio’s earnings last quarter?
Nuvation Bio released its earnings results on Nov 03, 2022. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.14 by $0.02.
Is Nuvation Bio overvalued?
According to Wall Street analysts Nuvation Bio’s price is currently Undervalued.
Does Nuvation Bio pay dividends?
Nuvation Bio does not currently pay dividends.
What is Nuvation Bio’s EPS estimate?
Nuvation Bio’s EPS estimate is -$0.12.
How many shares outstanding does Nuvation Bio have?
Nuvation Bio has 217,392,610 shares outstanding.
What happened to Nuvation Bio’s price movement after its last earnings report?
Nuvation Bio reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.14. Following the earnings report the stock price went down -2.336%.
Which hedge fund is a major shareholder of Nuvation Bio?
Among the largest hedge funds holding Nuvation Bio’s share is Omega Fund Management, LLC. It holds Nuvation Bio’s shares valued at 34M.
---
Nuvation Bio Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.25
$3.25
Hedge Fund Trend
Decreased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $483.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.82%
12-Months-Change
Fundamentals
Return on Equity
-15.10%
Trailing 12-Months
Asset Growth
-13.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nuvation Bio
Panacea Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
Evolus
―
Phathom Pharmaceuticals
―
Tarsus Pharmaceuticals
―
Rani Therapeutics Holdings
―
---